The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study EV-103: Preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
 
Jonathan E. Rosenberg
No Relationships to Disclose
 
Thomas W. Flaig
No Relationships to Disclose
 
Terence W. Friedlander
No Relationships to Disclose
 
Matthew I. Milowsky
No Relationships to Disclose
 
Sandy Srinivas
No Relationships to Disclose
 
Daniel Peter Petrylak
No Relationships to Disclose
 
Jaime R. Merchan
No Relationships to Disclose
 
Mehmet Asim Bilen
No Relationships to Disclose
 
Anne-Sophie Carret
No Relationships to Disclose
 
Nancy Yuan
No Relationships to Disclose
 
Carolyn Sasse
No Relationships to Disclose
 
Christopher J. Hoimes
No Relationships to Disclose